Realta | search
Click here to view Realta news from 60+ newspapers.
Bookmark or Share- ReAlta Life Sciences Receives FDA Clearance for Phase 2 Trial of RLS ...ReAlta Life Sciences, Inc. is a mid-stage clinical biotech company dedicated to harnessing the power of the immune system to address life threatening acute inflammatory and rare diseases.
- ReAlta Life Sciences Granted FDA Orphan Drug Designation and Fast Track ...ReAlta Life Sciences Granted FDA Orphan Drug Designation and Fast Track Designation for RLS-0071 for the Treatment of Steroid-Refractory Acute Graft-versus-Host Disease. Second clinical...
- ReAlta Life Sciences Announces First Patient Dosed in Phase 2 Study ...ReAlta Life Sciences, Inc. is a clinical mid-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address life threatening rare and acute inflammatory diseases. The Company’s EPICC peptide platform is based on discoveries related to the human astrovirus, HAstV-1, which causes a non-inflammatory ...
- ReAlta Life Sciences doses first patient in trial of graft-versus-host ...GlobalData. Tue, Sep 24, 2024, 4:52 AM 2 min read. US-based biopharmaceutical company ReAlta Life Sciences has dosed the first subject in its Phase II clinical trial of RLS-0071 for treating ...
- ReAlta Life Sciences, Inc.ReAlta Life Sciences, a clinical stage company focused on rare diseases, has developed a novel class of drugs with unique dual-targeting therapeutic capabilities that rebalance complement and inflammatory processes.
More
